Premium
Contrast induced nephropathy after coronary or vascular intervention: More biomarkers than answers
Author(s) -
Annamalai Shiva K.,
Kapur Navin K.
Publication year - 2018
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.27671
Subject(s) - medicine , creatinine , conventional pci , contrast induced nephropathy , cardiology , percutaneous coronary intervention , urinary system , cohort , renal function , circulatory system , nephropathy , intensive care medicine , myocardial infarction , diabetes mellitus , endocrinology
Key Points Rising urine NGAL and serum creatinine after 48 hr are potentially useful in predicting persistent creatinine increase in patients with contrast‐induced AKI. Urinary NGAL may allow for early identification of a high‐risk cohort following PCI. Future studies are needed to determine whether renal biomarkers are affected by clinical variables, such as heart failure acute mechanical circulatory support (AMCS) and whether they can be used to identify patients who would benefit from either AMCS reno‐protection during PCI remains unknown.